{"schema_version":"secwatch.filing_event.v1","accession":"0001387131-22-002256","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2022-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.446692+00:00","generated_at":"2026-06-27T06:33:59.461667+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Tonix Pharmaceuticals director Dr. Daniel Goodman will not stand for reelection at 2022 annual meeting","bullets":["Dr. Daniel Goodman notified Tonix on Feb 16, 2022, of his decision not to stand for reelection.","He will continue as director and retain committee memberships through the 2022 Annual Meeting.","No replacement director has been announced; the 2022 Annual Meeting date is not specified."],"urls":{"canonical":"https://secwatch.observer/filing/0001387131-22-002256","json":"https://secwatch.observer/filing/0001387131-22-002256.json","markdown":"https://secwatch.observer/filing/0001387131-22-002256.md","text":"https://secwatch.observer/filing/0001387131-22-002256.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002256/0001387131-22-002256-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002256/tnxp-8k_021622.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T06:33:59.461667+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dee72d73f6","claim":"Daniel Goodman departed as Director at Tonix Pharmaceuticals Holding Corp..","evidence_excerpt":"Dr. Daniel Goodman provided notice to Tonix Pharmaceuticals Holding Corp. (the “Company”) of his intention not to stand for reelection at the Company’s 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002256/0001387131-22-002256-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}